Injection, Solution

Influenza A Virus A/Victoria/2570/2019 Ivr-215 (H1n1) Antigen (Propiolactone Inactivated), Influenza A Virus A/Darwin/6/2021 Ivr-227 (H3n2) Antigen (Propiolactone Inactivated), Influenza B Virus B/Austria/1359417/2021 Bvr-26 Antigen (Propiolactone Inactivated), And Influenza B Virus B/Phuket/3073/2013 Bvr-1b Antigen (Propiolactone Inactivated)

Influenza A Virus A/Darwin/6/2021 Ivr-227 (H3n2) Antigen (Propiolactone Inactivated) + Influenza A Virus A/Victoria/2570/2019 Ivr-215 (H1n1) Antigen (Propiolactone Inactivated) + Influenza B Virus B/Austria/1359417/2021 Bvr-26 Antigen (Propiolactone Inactivated) + Influenza B Virus B/Phuket/3073/2013 Bvr-1b Antigen (Propiolactone Inactivated)

0 ACTIVE SUPPLIERS — US

openFDA · updated weekly

US1 NDCs
0 active makers

UKComing
soon

CAComing
soon

AUComing
soon

EUComing
soon

ATC—

RxCUI (US)—

US makers1 labelers

Packages1

DEA / ScheduleNone

Medicaid dispensing volume

No Medicaid utilization on record for this drug concept yet. Quarterly volume (CMS State Drug Utilization Data) loads with the utilization ETL.

Who makes it0 active · 1 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

Labeler	Type	Packages	Status
Patheon Inc.	unknown	1	EXITED 2026

Regulatory & supply events

No recalls, shortages, or registration changes on record for this drug concept.